Comment on FR Doc # 2026-09877, NRC-2025-1205-0001, from Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR)

Summary: The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR), an industry association representing manufacturers of radiopharmaceutical drugs and medical radionuclides, supports the NRC's proposed rulemaking to modernize regulations for byproduct material use. They argue that the updates will improve efficiency, reduce unnecessary regulatory burdens, and enhance regulatory consistency across various medical applications while maintaining safety standards.